Amgen

Another Biosimilar Legislative Defeat For Amgen & Genentech

Another Biosimilar Legislative Defeat For Amgen & Genentech

Pharmalot

Leading Biotechs Act Well But Be Careful Not To Chase

Leading Biotechs Act Well But Be Careful Not To Chase

Investors.com

Undervaluation Of Vical's Full Pipeline Allows A Cheap Bet On Cancer Trial

Undervaluation Of Vical's Full Pipeline Allows A Cheap Bet On Cancer Trial

Seeking Alpha

Big drugmakers think small with nanomedicine deals

Big drugmakers think small with nanomedicine deals

Reuters

EPO Pills: A Challenge For Amgen And Johnson & Johnson

EPO Pills: A Challenge For Amgen And Johnson & Johnson

Seeking Alpha

Cytokinetics: A New Approach to Treating a Broken Heart

Cytokinetics: A New Approach to Treating a Broken Heart

Motley Fool

Enbrel's Asian Biosimilar Competitors

Enbrel's Asian Biosimilar Competitors

Seeking Alpha

In Moribund Cholesterol Field, A New Drug Emerges

In Moribund Cholesterol Field, A New Drug Emerges

Forbes

Amgen 1Q profit up 21 pct on lower taxes, expenses

Amgen 1Q profit up 21 pct on lower taxes, expenses

Yahoo/AP

Melanoma: Battle Of 3 Cancer Vaccines

Melanoma: Battle Of 3 Cancer Vaccines

Seeking Alpha